
Asymchem Laboratories (Tianjin) Co., Ltd.
6821.HKHKSEHealthcareBiotechnology
最新データ
HK$111.1
−HK$8.70 · -7.26%
6821.HKの企業概要
日中の時刻はHKTです。市場データは遅延する場合があります。
企業プロフィール
会社ウェブサイトAsymchem Laboratories (Tianjin) Co., Ltd. functions as a Contract Development and Manufacturing Organization (CDMO), offering its services to clients across Mainland China and internationally. The company delivers extensive drug research, development, and manufacturing solutions specifically tailored for pharmaceutical and biotechnology enterprises. Their offerings are comprehensive, covering the entire lifecycle from early clinical stages through to full commercialization, including R&D and cGMP compliant production of advanced intermediates, active pharmaceutical ingredients (APIs), and finished formulations, alongside clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the sale and distribution of medicinal products, and active participation in pharmaceutical science and technology innovation. The company was founded in 1999 and maintains its headquarters in Tianjin, China.
- 業界
- Biotechnology
- セクター
- Healthcare
- 本社
- CN
- 最高経営責任者(CEO)
- Hao Hong
- 上場以来
- 2021年12月10日
- 従業員
- 10,617
市場での位置
- 出来高
- 172.29万
- 2.04× 平均
- 平均出来高
- 84.52万
- 1日平均出来高
- 時価総額
- 400.83億 HKD
- ベータ
- 0.06
- 市場参照 1
6821.HKの同業他社
GoAI で研究を続ける
GoAIで6821.HKを調査research.disclaimer





